Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Technetium Tc-99m etifenin is a radiopharmaceutical agent used primarily for imaging studies of the liver and biliary tract. It is administered intravenously and accumulates in hepatocytes, allowing visualization of hepatic function and biliary excretion through gamma camera imaging. The compound contains the radioisotope technetium-99m, which emits gamma radiation detectable by nuclear medicine equipment. Its mechanism relies on selective uptake by functioning hepatocytes and subsequent excretion into the bile ducts, enabling assessment of liver function, gallbladder patency, and biliary tract integrity[2][4]. Technetium Tc-99m etifenin belongs to the class of organic compounds known as alpha amino acid amides[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on technetium tc-99m etifenin.